Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01639157 · ClinicalTrials.gov registry record · NA

Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine

A NA study, sponsored by William Stoops.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT01639157 is a NA study that has completed, run by William Stoops. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01639157, a NA study, has completed, sponsored by William Stoops.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Cocaine use disorders are an unrelenting public health concern. Intensive research efforts have yielded behavioral interventions that reduce cocaine use, however, these interventions are not universally effective and treatment effects diminish over time. Development of a pharmacotherapy that enhances the efficacy of these interventions is a priority for the National Institute on Drug Abuse. This study proposes to determine the impact of buspirone maintenance on self-administration of cocaine and alternative reinforcers. These preliminary data will be used to support further research developing buspirone as a pharmacotherapy for cocaine use disorders. We hypothesize that buspirone will attenuate the reinforcing effects of cocaine and increase the reinforcing effects of alternative reinforcers.

Interventions

  • DRUG Placebo
  • DRUG Buspirone

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2012-09
Est. Completion 2014-12
Phase NA

Sponsor

William Stoops

13 total trials

What the Registry Record Tells You About NCT01639157

The ClinicalTrials.gov registry entry for NCT01639157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is William Stoops, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01639157 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01639157 about?

NCT01639157 is a clinical study titled "Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine". Cocaine use disorders are an unrelenting public health concern. Intensive research efforts have yielded behavioral interventions that reduce cocaine use, however, these interventions are not universally effective and treatment effects diminish over time. Development of a pharmacotherapy that enhance...

What is the current status of trial NCT01639157?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-09. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01639157?

The interventions under investigation include: Placebo (DRUG), Buspirone (DRUG).

Who is sponsoring clinical trial NCT01639157?

This trial is sponsored by William Stoops, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.